ArticleEuropean journal of medical research2026
Ceramide-based machine learning models for the diagnosis of unstable angina: a prospective multicenter study.
Article in European journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundCoronary artery disease is a critical public health issue. While traditional biomarkers like cardiac troponin show high sensitivity, their utility in unstable angina (UA) patients is limited. Recent research has identified novel biomarkers, including ceramides, which may correlate with atherosclerotic plaque stability and acute coronary syndrome (ACS) risk. This study aimed to develop a machine learning-based model to evaluate ceramide's diagnostic efficacy in patients with UA.
methodsWe conducted a prospective study from April 2021 to August 2022 at two medical centers, comparing data from UA patients with controls (stable angina and non-coronary patients). Data were split into training and validation sets. We assessed seven machine learning algorithms, including Extreme Gradient Boosting (XGBoost), Gradient Boosting Machine (GBM), Distributed Random Forest (DRF), Extremely Randomized Trees (XRT), Deep Neural Networks (DNN), and Generalized Linear Models (GLM), using stacked ensemble models for improved predictions. Predictive accuracy was evaluated with the receiver operating characteristic area under the curve (ROC AUC), and model calibration was assessed using calibration curves. Feature importance was analyzed using the SHAP method.
resultsA total of 835 participants were recruited for the study, comprising 649 individuals diagnosed with unstable angina (UA) and 186 control subjects. The dataset was randomly divided into a derivation cohort consisting of 664 participants and a validation cohort comprising 171 participants. After comparing predictive models, we selected a generalized linear model with L1 regularization, demonstrating a strong ability to distinguish UA patients from controls (ROC AUC: 0.85, 95% CI 0.81-0.88). Calibration curve analysis indicated an intercept of 0.00 (95% CI - 0.21-0.21) and a slope of 1.05 (95% CI 0.86-1.25). Cer16:0 and Cer24:1 emerged as key predictors based on SHAP values.
conclusionThe machine learning model combining ceramide and conventional clinical variables effectively diagnoses UA, improving clinical efficacy. Future studies will validate and refine this model through expanded multicenter research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.